Suppliers / Hanoi Cpc1 Pharmaceutical Joint Stock

Hanoi Cpc1 Pharmaceutical Joint Stock

United Arab Emirates 368 employees Updated 9 July 2026

Hanoi Cpc1 Pharmaceutical Joint Stock is an API and finished-dose manufacturer based in United Arab Emirates. It appears in 29 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), JFDA (JO) and DIGEMAPS (DO).

0
active US DMFs
0
valid CEPs
1
registered plants
29
filings across 3 regulators

Registered plants

Site FDA FEI
Hanoi, United Arab Emirates Not on file

What they file, and where

Molecule Regulators Docs
Acetylcysteine DAV (Vietnam) 1
Galantamine DAV (Vietnam) 1
Hydroxocobalamin DAV (Vietnam) 1
Levobupivacaine DAV (Vietnam) 1
Levofloxacin DAV (Vietnam) 1
Minoxidil DAV (Vietnam) 1
Moxifloxacin DAV (Vietnam) 1
Neostigmine DAV (Vietnam) 1
Norepinephrine DAV (Vietnam) 1
Rocuronium DAV (Vietnam) 1
Show all 13 molecules on file
Sodium Bicarbonate DAV (Vietnam) 1
Terbutaline DAV (Vietnam) 1
Ursodeoxycholic Acid DAV (Vietnam) 1

Also appears on these molecule pages

Terbutaline finished dose Levofloxacin API Ursodeoxycholic Acid API Minoxidil API Acetylcysteine API Moxifloxacin API

Filings and GMP by regulator

Regulator Filings GMP certificates
EDE (AE) 27 None
JFDA (JO) 1 None
DIGEMAPS (DO) 1 None

Comparing suppliers?

Choose your molecules and target markets. Hanoi Cpc1 Pharmaceutical Joint Stock comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability